10 examples
Testbiotech shows increasing number of patents on food plants and New GE
Project Genetic Engineering and the Environment // Background Information Videos
Gene Drive - intervention in the "germline" of natural diversity
previous pauseresume next

EFSA favours cultivation of 'Roundup Ready Soy' within the EU

But new legal dossier shows current authorisation practice violates EU law
Friday, 22 June 2012

The European Food Safety Authority EFSA has for the first time given a positive opinion on the cultivation of genetically engineered soy in the EU. Now the EU Commission and Member States have to make a decision on final market authorisation. The applicant, US company Monsanto, wants to sell its seeds for herbicide tolerant Roundup Ready soy to European farmers. Currently, the genetically engineered soy can be imported but not grown.

Invitation to media event - Genetically engineered plants and independent risk research

Testbiotech invites the media to join them for presentations and discussions on the risks of genetically engineered plants and support for independent risk research. The media event will take place on 14 June 2012 at the Haus der Wissenschaft in Bremen.

Biotech industry - hidden influence in Germany

Conflicts of interest at government authorities and German Research Foundation (DFG)
Thursday, 24 May 2012

A new Testbiotech report reveals some, at least partially, hidden networks enabling the biotech industry to influence state authorities and research institutions dealing with genetically engineered plants. The authorities involved include the German Federal Institute for Risk Assessment (BfR), the research institutes of the German ministry of agriculture (BMELV) and a committee at the German Research Foundation (DFG). The report identifies 17 experts with conflicts of interest.

Opposition to patent on human sperm cells

Company Ovasort holds a patent on sex selection
Tuesday, 15 May 2012

Testbiotech has filed an opposition to a patent (EP1263521) held by Ovasort (UK). The patent covers human sperm cells selected for their sex intended for use in in-vitro fertilisation and the production of female offspring. The patent violates European Patent law, which prohibits patents on human germ cells and the development of the human body. Nevertheless, the European Patent Office has granted such patents several times.


Alle | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009